Global Regulatory Lead – Cardiovascular NDA Strategy

Planet Pharma

Overland Park (KS)

On-site

USD 164,000 - 178,000

Full time

8 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Planet Pharma seeks a Global Regulatory Lead (GRL) / US Regulatory Lead (USRL) to provide strategic regulatory leadership for a late‑stage cardiovascular development program, serving as the primary regulatory lead for Milvexian. The role drives global regulatory strategy, health authority engagement, and cross‑functional collaboration across partner organizations.

The candidate will guide NDA readiness, submissions, and review activities, oversee global submission workstreams, and ensure

Qualifications

  • Solid scientific background with PhD, MD, PharmD, MS or BS in a relevant discipline.
  • Regulatory Affairs experience (4–7+ years) in cardiovascular drug development.

Responsibilities

  • Serve as Global Regulatory Lead (GRL) and/or US Regulatory Lead (USRL) for a late-stage cardiovascular development program.
  • Lead global regulatory strategy for the Milvexian indication and align with program objectives and business goals.
  • Provide regulatory leadership through key milestones including DBL, NDA preparation, submission and review activities.
  • Lead internal and joint Global Regulatory Teams (GRTs) to drive collaboration and execution across partner organizations.
  • Drive preparation and regulatory readiness for the original NDA submission in progress.
  • Provide global submission leadership with integrated submission planning, cross-functional alignment, risk identification and high-quality execution across global workstreams.
  • Develop product registration strategies and translate them into actionable operational plans.
  • Create alternative regulatory pathways and risk mitigation strategies to achieve program objectives.
  • Formulate U.S. regulatory strategies and oversee submission activities.

Skills

Regulatory leadership
Cardiovascular drugs
GxP regulatory strategy

Education

PhD/MD/PharmD/MS/BS in a relevant scientific discipline

Job description

Planet Pharma seeks a Global Regulatory Lead (GRL) / US Regulatory Lead (USRL) to provide strategic regulatory leadership for a late‑stage cardiovascular development program, serving as the primary regulatory lead for Milvexian. The role drives global regulatory strategy, health authority engagement, and cross‑functional collaboration across partner organizations.

The candidate will guide NDA readiness, submissions, and review activities, oversee global submission workstreams, and ensure

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Cardiovascular Regulatory Lead | NDA Strategy
Global Cardiovascular Regulatory Lead | NDA Strategy

Medasource • New Jersey

On-site
USD 150,000 - 210,000
Global Regulatory Affairs Lead
Global Regulatory Affairs Lead

Medasource • New Jersey

On-site
USD 150,000 - 210,000
Remote Global Regulatory Lead - Cardiovascular NDA
Remote Global Regulatory Lead - Cardiovascular NDA

Medasource • United States

Remote
USD 165,000 - 193,000
Global Regulatory Lead (GRL) / US Regulatory Lead (USRL)
Global Regulatory Lead (GRL) / US Regulatory Lead (USRL)

Planet Pharma • Overland Park (KS)

On-site
USD 164,000 - 178,000
Remote Global Regulatory Lead: Cardiovascular
Remote Global Regulatory Lead: Cardiovascular

Apex Systems • Overland Park (KS)

Remote
USD 160,000 - 210,000
Health insurance
401K
ESPP
+5
Global Regulatory Lead
Global Regulatory Lead

Medasource • United States

Remote
USD 165,000 - 193,000
Global Regulatory Lead: Cardiovascular NDA Strategy
Global Regulatory Lead: Cardiovascular NDA Strategy

The Panther Group • Overland Park (KS)

On-site
USD 107,000 - 179,000
Global Regulatory Strategy Lead
Global Regulatory Strategy Lead

Kardigan • Princeton (NJ)

On-site
USD 266,000 - 346,000
Global Regulatory Lead (Early and Late Phase) – Neuroscience
Global Regulatory Lead (Early and Late Phase) – Neuroscience

Eli Lilly and Company • Indianapolis (IN)

On-site
USD 180,000 - 240,000
Global Medical Lead, Cardiovascular – Milvexian
Global Medical Lead, Cardiovascular – Milvexian

Bristol-Myers Squibb Co • New Jersey

On-site
USD 229,000 - 278,000